Dyadic International, Inc. (NASDAQ:DYAI) Sees Large Decrease in Short Interest

Dyadic International, Inc. (NASDAQ:DYAI) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 96,600 shares, a decrease of 19.9% from the February 13th total of 120,600 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily volume of 90,700 shares, the days-to-cover ratio is presently 1.1 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in DYAI. Truist Financial Corp acquired a new position in Dyadic International during the 4th quarter worth about $428,000. Inlet Private Wealth LLC acquired a new position in Dyadic International during the 4th quarter worth about $52,000. Bank of America Corp DE lifted its position in Dyadic International by 16,146.7% during the 4th quarter. Bank of America Corp DE now owns 27,132 shares of the biotechnology company’s stock worth $47,000 after buying an additional 26,965 shares in the last quarter. Jane Street Group LLC acquired a new position in Dyadic International during the 4th quarter worth about $45,000. Finally, Millennium Management LLC acquired a new position in Dyadic International during the 4th quarter worth about $28,000. Institutional investors and hedge funds own 27.95% of the company’s stock.

Dyadic International Price Performance

Shares of DYAI traded up $0.05 during trading hours on Wednesday, hitting $1.43. The stock had a trading volume of 62,830 shares, compared to its average volume of 68,917. The company’s fifty day moving average is $1.51 and its two-hundred day moving average is $1.42. The company has a debt-to-equity ratio of 1.54, a current ratio of 5.15 and a quick ratio of 5.15. Dyadic International has a 52 week low of $0.93 and a 52 week high of $2.67. The stock has a market capitalization of $42.31 million, a price-to-earnings ratio of -6.22 and a beta of 0.95.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.